Dementia, Non-Alzheimer's


The Association for Frontotemporal Dementias

In addition to a thorough introduction to frontotemporal dementias, The Association for Frontotemporal Dementias provides specific diagnostic and clinical information for a variety of disorders, including Pick's Disease and progressive aphasia.

The Lewy Body Dementia Association

In addition to publishing a newsletter and hosting email support groups for care-givers and spouses of Lewy Body Dementia patients, the LBDA Web site contains patient care tips and links to scientific journal articles about LBD.

NINDS Dementia with Lewy Bodies Information Page

This page provides a succinct description of Lewy Body Dementia, as well as information about clinical trials.

NINDS Pick's Disease Information Page

The National Institute of Neurological Disorders and strokes briefly describes Pick's Disease and provides links to relevant clinical trials.

UCSF Memory and Aging Center

This University of California, San Francisco site offers information on different forms of dementia, along with healthy aging and memory.

Dana Articles

The Malignant Protein Puzzle

(Read Q&A with Lary C. Walker Ph.D.)
Studying how proteins such as PrP, amyloid beta, tau, and others aggregate and spread, and kill brain cells, represents a crucial new frontier in neuroscience for Alzheimer's, Parkinson's, CTE, and ALS.

Air Pollution Also Not Good For Your Brain

Recent research provides strong evidence that pollutants cause harms, and suggests underlying pathways and mechanisms. 

Purpose in Life: Q&A with Adam Kaplin

Purpose in Life (PIL) is a research area that focuses on the interactions between mind and body and the powerful ways in which emotional, mental, social, and spiritual factors can directly affect health. It links the belief that your life has meaning and purpose to a robust and persistently improved physiological health outcome—particularly as a way to treat dementia, spinal cord injuries, stroke, and immunological and cardiovascular issues that include but extend beyond the brain. An interview with Adam Kaplin, MD, PhD, one of the co-authors of the May 2015 Cerebrum essay on PIL.

The Mysteries of Tau: Q&A with Kenneth S. Kosik

Kenneth S. Kosik, MD, was a member of one of several research groups that originally discovered tau protein in the Alzheimer’s neurofibrillary tangle. In this month’s Cerebrum feature, “ Tau-er of Power,” he points out that if he and other tau researchers can better understand tau, then progress can be made in fighting neurological disorders linked to this protein, including frontotemporal dementia, chronic traumatic encephalopathy (CTE), and Alzheimer’s disease.

What Does it Mean to be ‘Amyloid Positive?’

Studies suggest amyloid accumulates for 3 decades or more before dementia symptoms show.

Target: Tau

Scientists have new insights into how the tau protein spreads within and harms the brain, in Alzheimer’s and other diseases--and tau-targeting therapies are now entering clinical trials.